Posters

Posters

2024

ASH

Measurable Residual Mutated NPM1 Before Allogenic Transplant For Acute Myeloid Leukemia  

DOWNLOAD ⟶

AMP

MRD in AML Biomarkers Consortium: Evaluation of Methods for Detection of FLT3 Internal Tandem Duplication Measurable Residual Disease in Acute Myeloid Leukemia 

DOWNLOAD ⟶

High-Throughput Multiplex MRD Assay for Prognostic Markers in AML Utilizing DNBSEQ-G99 Sequencer

DOWNLOAD ⟶

The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶

Assessment of FLT3 Somatic Variant Oncogenicity using FLT3-Gene-Specific Guidelines in Acute Myeloid Leukemia

DOWNLOAD ⟶

The Challenges of Developing Classification Guidelines for Fusions in AML; How and When to Use a KMT2A Fusion-Specific Workflow

DOWNLOAD ⟶

AMP Europe

Performance Comparison of Nine Different Assays Between Next Generation Sequencing (NGS) Platforms
DOWNLOAD ⟶

IdentiClone® RUO TCRG 2.0 Software for Capillary-Based Detection of T-Cell Receptor Gamma Gene Rearrangements
DOWNLOAD ⟶

2023

AMP

Artifact and Background Calculator Identifies Patterns of False Positive Variant Calls in Clinical NGS Panels
DOWNLOAD ⟶

Evaluation of a High-Throughput CDR3 Identification Algorithm for 1136 Clinical Samples Targeting the IGHV Leader, IGH FR1, and TRG Loci
DOWNLOAD ⟶

AMP Europe

Measurable Residual Disease Detection in Mantle Cell Lymphoma (MCL) Subjects Using NGS B-Cell MRD Assay
DOWNLOAD ⟶

EHA

A Prospective Study of TCR Measurable Residual Disease in Peripheral T-Cell Lymphoma
DOWNLOAD ⟶

ASCO

A Multi-Institutional Prospective Cohort Study of Minimal Residual Disease in Peripheral T-cell Lymphoma: Impact of Autologous Stem Cell Transplant
DOWNLOAD ⟶

2022

EAHP
Detecting Clonality in Mantle Cell Lymphoma (MCL) Subjects Using LymphoTrack® IGH FR1 Assays
DOWNLOAD ⟶
AMP

Validate an NGS Based Measurable Residual Disease (MRD) Assay for B-Cell Lymphoproliferative Diseases
DOWNLOAD ⟶

Tracking Measurable Residual Disease in Acute Myeloid Leukemia with Error Corrected Sequencing
DOWNLOAD ⟶
SNPrint: Customizable Genotyper for Clinical Sample Tracking and Disease Progression Monitoring for NGS-Based Targeted Gene Panels
DOWNLOAD ⟶
EHA

A Sensitive NGS Assay to Detect Measurable Residual Disease (MRD) in B-cell Lymphoproliferative Diseases
DOWNLOAD ⟶

2020

ASH
End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-cell Lymphomas
DOWNLOAD ⟶
EHA
TRG Clonality Interrogation by CE and NGS: Bridging the Gap Between Classical and Leading Edge Technologies
DOWNLOAD ⟶

2019

AMP
A Next-Generation Sequencing Based Analysis of Clonality across 39 Subjects Treated for Lymphoproliferative Disorders Reveals Matching Clones in the Diverse IGH Locus
DOWNLOAD ⟶
Comparing DNA Extraction Methods for the LymphoTrack® IVD TRG Assay
DOWNLOAD ⟶
Evaluation of An Alternative Fragmentation Method in High Throughput NGS Sample Testing of Minimal Residual Disease in Hematological Malignancies
DOWNLOAD ⟶
Validation of an NGS based assay for monitoring FLT3 ITD and TKD variants in AML subjects
DOWNLOAD ⟶
Comparing Minimal Residual Disease Detection in Multiple Myeloma using NGS-Based LymphoTrack® Assays and Flow Cytometry
DOWNLOAD ⟶
LymphoTrack® Low Positive Control and LymphoQuant® Internal Control for MiSeq™ and Ion S5/PGM™ LymphoTrack Assays
DOWNLOAD ⟶
Error Rate Normalization to Establish Position-Specific LoB & LoD in Next Generation Sequencing Assays
DOWNLOAD ⟶

2018

AMP

Minimal Residual Disease in AML can be Monitored Utilizing Cell-Free DNA
DOWNLOAD ⟶

Detection of Clonal Rearrangements in Multiple Myeloma Samples using LymphoTrack® Assays
DOWNLOAD ⟶
Performance Evaluation of LymphoTrack® Clonality Assays on Ion PGM<sup™ and Ion S5<sup™ Platforms
DOWNLOAD ⟶
EHA
Comparison of LymphoTrack® Assays – MiSeq™ and Flow Cytometry for Clonality and Minimum Residual Disease Assessment in Multiple Myeloma
DOWNLOAD ⟶
Cell-Free DNA Monitoring of Minimal Residual Disease in AML using a Targeted NGS Gene Panel
DOWNLOAD ⟶

2017

AMP

Small Customizable Next-Generation Sequencing Based Target-Capture Panels in a Clinical Environment Can Detect Variant Mutations at Frequencies as Low as 0.5%
DOWNLOAD ⟶

Small Detecting B-Cell Clonality in Clinical Samples using a Comprehensive NGS LymphoTrack Dx® IGH FR1/2/3 Assay
DOWNLOAD ⟶
Assessment of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Monitoring FLT3 and NPM1 Mutations
DOWNLOAD ⟶
Genetic Heterogeneity and Stratification of AML Samples with NPM1 Mutation Detected by the MyAML® NGS Test
DOWNLOAD ⟶
Clonality Detection Using Next-Generation Sequencing and Capillary Electrophoresis Methods in Suspect Lymphoproliferative Samples
DOWNLOAD ⟶
Validation of the LeukoStrat® CDx FLT3 Mutation Assay: Used to Detect both Internal Tandem Duplication (ITD) and Tyrosine Kinase Domain (TKD) Mutations and Response to Midostaurin in 1058 Patients with AML
DOWNLOAD ⟶
Multiple Highly Concordant Assays Facilitate Analyses of Clinical Samples at Different Scales and Sensitivities
DOWNLOAD ⟶
Detection of Clonal TRG and TRB Gene Rearrangements Using Next-Generation Sequencing
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
DOWNLOAD ⟶
EHA
Small Customizable NGS Based Target Capture Panels Detect Variants in Clinical Specimens at Frequencies as Low as 0.5%
DOWNLOAD ⟶
Use of a Small Targeted Next-Generation Sequencing Panel for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia
DOWNLOAD ⟶
Using Next-Generation Sequencing to Detect Clonal TRG and TRB Gene Rearrangements
DOWNLOAD ⟶
Detection of Clonality in Clinical Specimens from Suspected B-cell Malignancies using Comprehensive IGH (FR1/2/3) LymphoTrack® MiSeq™ and PGM™ Assays
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes IGH (FR1/2/3) LymphoTrack® MiSeq™ and PGM™ Assays
DOWNLOAD ⟶

2016

AMP
Minimal Residual Disease Detection of Lymphoid and Plasma Cell Neoplasms Using a Next-Generation Sequencing (NGS)-Based Assay
DOWNLOAD ⟶

Detection of Clonal Immunoglobulin and T-cell Receptor Gene Rearrangements in Acute Myeloid Leukemia
DOWNLOAD ⟶

LOD and Sensitivity of MyHEME: A Comprehensive Targeted Sequencing Strategy
DOWNLOAD ⟶

Next-Generation Sequencing of FLT3/ITD for Minimal Residual Disease Monitoring in Leukemia Patients
DOWNLOAD ⟶
Next-Generation Sequencing of NPM1 for Minimal Residual Disease Monitoring in Leukemia Patients
DOWNLOAD ⟶
Development of a Comprehensive IGH NGS Assay for Detecting Suspected B-Cell Clonality
DOWNLOAD ⟶
A Single Institution Experience Using Next Generation Sequencing (NGS) for Analysis of Immunoglobulin Heavy Chain Variable Region (IGVH) Somatic Hypermutation in Chronic Lymphocytic Leukemia
DOWNLOAD ⟶
Next Generation Sequencing Demonstrates Clinical Utility and Increased Sensitivity in Detection of IgVH Somatic Hypermutation in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
DOWNLOAD ⟶
Assessment of Immunoglobulin Heavy Variable Gene Usage and Somatic Hypermutation Status in Splenic Marginal Zone Lymphomas Using Next Generation Sequencing
DOWNLOAD ⟶

2015

AMP
Development of LymphoTrack® Bioinformatics Methods: Clonality Testing, Somatic Hypermutation and Minimal Residual Disease
DOWNLOAD ⟶

Validation and clinical implementation of next generation sequencing for routine IGH and TCRG clonality assessment
DOWNLOAD ⟶

Next-Generation Sequencing for Detection of Clonal TRG Gene Rearrangements Shows Improved Specificity and Positive Predictive Value Compared to Fragment Analysis Using BIOMED-2 Primers and Capillary Electrophoresis
DOWNLOAD ⟶
EHA

Clinical Assessment of Chronic Lymphocytic Leukemia (CLL) Samples for Somatic Hypermutation Status by Next-Generation Sequencing and Sanger Sequencing
DOWNLOAD ⟶

Development of an NGS Assay for IGK that can be combined with IGH for Identifying Clonal Populations in Lymphoid Malignancies
DOWNLOAD ⟶

2024

AMP

High-Throughput Multiplex MRD Assay for Prognostic Markers in AML Utilizing DNBSEQ-G99 Sequencer

DOWNLOAD ⟶

The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶

Assessment of FLT3 Somatic Variant Oncogenicity using FLT3-Gene-Specific Guidelines in Acute Myeloid Leukemia

DOWNLOAD ⟶

The Challenges of Developing Classification Guidelines for Fusions in AML; How and When to Use a KMT2A Fusion-Specific Workflow

DOWNLOAD ⟶

AMP Europe

The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶

2023

AMP

The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶

Artifact and Background Calculator Identifies Patterns of False Positive Variant Calls in Clinical NGS Panels
DOWNLOAD ⟶

Evaluation of a High-Throughput CDR3 Identification Algorithm for 1136 Clinical Samples Targeting the IGHV Leader, IGH FR1, and TRG Loci
DOWNLOAD ⟶

AMP Europe

Measurable Residual Disease Detection in Mantle Cell Lymphoma (MCL) Subjects Using NGS B-Cell MRD Assay
DOWNLOAD ⟶

EHA

A Prospective Study of TCR Measurable Residual Disease in Peripheral T-Cell Lymphoma
DOWNLOAD ⟶

ASCO

A Multi-Institutional Prospective Cohort Study of Minimal Residual Disease in Peripheral T-cell Lymphoma: Impact of Autologous Stem Cell Transplant
DOWNLOAD ⟶

2022

EAHP

Detecting Clonality in Mantle Cell Lymphoma (MCL) Subjects Using LymphoTrack® IGH FR1 Assays
DOWNLOAD ⟶

AMP

Validate an NGS Based Measurable Residual Disease (MRD) Assay for B-Cell Lymphoproliferative Diseases
DOWNLOAD ⟶

Tracking Measurable Residual Disease in Acute Myeloid Leukemia with Error Corrected Sequencing
DOWNLOAD ⟶

SNPrint: Customizable Genotyper for Clinical Sample Tracking and Disease Progression Monitoring for NGS-Based Targeted Gene Panels
DOWNLOAD ⟶

EHA

A Sensitive NGS Assay to Detect Measurable Residual Disease (MRD) in B-cell Lymphoproliferative Diseases
DOWNLOAD ⟶

2020

ASH
End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-cell Lymphomas
DOWNLOAD ⟶
EHA
TRG Clonality Interrogation by CE and NGS: Bridging the Gap Between Classical and Leading Edge Technologies
DOWNLOAD ⟶

2019

AMP
A Next-Generation Sequencing Based Analysis of Clonality across 39 Subjects Treated for Lymphoproliferative
Disorders Reveals Matching Clones in the Diverse IGH Locus
DOWNLOAD ⟶
Comparing DNA Extraction Methods for the LymphoTrack® IVD TRG Assay
DOWNLOAD ⟶
Evaluation of An Alternative Fragmentation Method in High Throughput NGS Sample Testing of Minimal Residual Disease in Hematological Malignancies
DOWNLOAD ⟶
Validation of an NGS based assay for monitoring FLT3 ITD and TKD variants in AML subjects
DOWNLOAD ⟶
Comparing Minimal Residual Disease Detection in Multiple Myeloma using NGS-Based LymphoTrack® Assays and Flow Cytometry
DOWNLOAD ⟶
LymphoTrack® Low Positive Control and LymphoQuant® Internal Control for MiSeq™ and Ion S5/PGM™ LymphoTrack Assays
DOWNLOAD ⟶
Error Rate Normalization to Establish Position-Specific LoB & LoD in Next Generation Sequencing Assays
DOWNLOAD ⟶

2018

AMP

Minimal Residual Disease in AML can be Monitored Utilizing Cell-Free DNA
DOWNLOAD ⟶

Detection of Clonal Rearrangements in Multiple Myeloma Samples using LymphoTrack® Assays
DOWNLOAD ⟶

Performance Evaluation of LymphoTrack® Clonality Assays on Ion PGM™ and Ion S5™ Platforms
DOWNLOAD ⟶

EHA
Comparison of LymphoTrack® Assays – MiSeq™ and Flow Cytometry for Clonality and Minimum Residual Disease Assessment in Multiple Myeloma
DOWNLOAD ⟶
Cell-Free DNA Monitoring of Minimal Residual Disease in AML using a Targeted NGS Gene Panel
DOWNLOAD ⟶

2017

AMP

Small Customizable Next-Genera5on Sequencing Based Target-Capture Panels in a Clinical Environment Can Detect Variant Muta5ons at Frequencies as Low as 0.5%
DOWNLOAD ⟶

Small Detec3ng B-Cell Clonality in Clinical Samples using a Comprehensive NGS LymphoTrack Dx® IGH FR1/2/3 Assay
DOWNLOAD ⟶
Assessment of Minimal Residual Disease in Pa3ents with Acute Myeloid Leukemia by Monitoring FLT3 and NPM1 Mutations
DOWNLOAD ⟶
Genetic Heterogeneity and Stratification of AML Samples with NPM1 Mutation Detected by the MyAML® NGS Test
DOWNLOAD ⟶
Clonality Detection Using Next-Generation Sequencing and Capillary Electrophoresis Methods in Suspect Lymphoproliferative Samples
DOWNLOAD ⟶
Validation of the LeukoStrat® CDx FLT3 Mutation Assay: Used to Detect both Internal Tandem Duplication (ITD) and Tyrosine Kinase Domain (TKD) Mutations and Response to Midostaurin in 1058 Patients with AML
DOWNLOAD ⟶
Multiple Highly Concordant Assays Facilitate Analyses of Clinical Samples at Different Scales and Sensitivities
DOWNLOAD ⟶
Detection of Clonal TRG and TRB Gene Rearrangements Using Next-Generation Sequencing
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
DOWNLOAD ⟶
EHA
Small Customizable NGS Based Target Capture Panels Detect Variants in Clinical Specimens at Frequencies as Low as 0.5%
DOWNLOAD ⟶
Use of a Small Targeted Next-Generation Sequencing Panel for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia
DOWNLOAD ⟶
Using Next-Generation Sequencing to Detect Clonal TRG and TRB Gene Rearrangements
DOWNLOAD ⟶
Detection of Clonality in Clinical Specimens from Suspected B-cell Malignancies using ComprehensiveIGH (FR1/2/3) LymphoTrack® MiSeq™ and PGM® Assays
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 GenesIGH (FR1/2/3) LymphoTrack® MiSeq™ and PGM® Assays
DOWNLOAD ⟶

2016

AMP
Minimal Residual Disease Detection of Lymphoid and Plasma Cell Neoplasms Using a Next-Generation Sequencing (NGS)-Based Assay
DOWNLOAD ⟶
Detec1on of Clonal Immunoglobulin and T-cell Receptor Gene Rearrangements in Acute Myeloid Leukemia
DOWNLOAD ⟶
LOD and Sensi;vity of MyHEME: A Comprehensive Targeted Sequencing Strategy
DOWNLOAD ⟶
Next-Generation Sequencing of FLT3/ITD for Minimal Residual Disease Monitoring in
Leukemia Patients
DOWNLOAD ⟶
Next-Generation Sequencing of NPM1 for Minimal Residual Disease Monitoring in Leukemia Patients
DOWNLOAD ⟶
Development of a Comprehensive IGH NGS Assay for DetecQng Suspected B-Cell Clonality
DOWNLOAD ⟶
A Single Institution Experience Using Next Generation Sequencing (NGS) for Analysis of Immunoglobulin Heavy Chain Variable Region (IGVH) Somatic Hypermutation in Chronic Lymphocytic Leukemia
DOWNLOAD ⟶
Next Generation Sequencing Demonstrates Clinical Utility and Increased Sensitivity in Detection of IgVH Somatic Hypermutation in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
DOWNLOAD ⟶
Assessment of Immunoglobulin Heavy Variable Gene Usage and Somatic Hypermutation Status in Splenic Marginal Zone Lymphomas Using Next Generation Sequencing
DOWNLOAD ⟶

2015

AMP

Development of LymphoTrack® Bioinformatics Methods: Clonality Testing, Somatic Hypermutation and Minimal Residual Disease
DOWNLOAD ⟶

Validation and clinical implementation of next generation sequencing for routine IGH and TCRG clonality assessment
DOWNLOAD ⟶

Next-Generation Sequencing for Detection of Clonal TRG Gene Rearrangements Shows Improved Specificity and Positive Predictive Value Compared to Fragment Analysis Using BIOMED-2 Primers and Capillary Electrophoresis
DOWNLOAD ⟶

EHA

Clinical Assessment of Chronic Lymphocytic Leukemia (CLL) Samples for Somatic Hypermutation Status by Next-Generation Sequencing and Sanger Sequencing
DOWNLOAD ⟶

Development of an NGS Assay for IGK that can be combined with IGH for Identifying Clonal Populations in Lymphoid Malignancies
DOWNLOAD ⟶